Grantham, Mayo, Van Otterloo & Co (GMO)
NUE icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Nucor NUE Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NUE Stock Details NUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.3M Sell
203,235
-54,752
-21% -$12.4M 0.1% 80
2026
Q1 		$43.6M Buy
257,987
+14,050
+6% +$2.45M 0.11% 80
2025
Q4 		$39.8M Buy
243,937
+29,827
+14% +$4.48M 0.1% 87
2025
Q3 		$29M Buy
214,110
+2,975
+1% +$421K 0.08% 127
2025
Q2 		$27.4M Sell
211,135
-60,277
-22% -$7.04M 0.08% 135
2025
Q1 		$32.7M Sell
271,412
-1,852
-0.7% -$239K 0.1% 130
2024
Q4 		$31.9M Sell
273,264
-837
-0.3% -$120K 0.1% 128
2024
Q3 		$41.2M Buy
274,101
+13,866
+5% +$2.09M 0.13% 110
2024
Q2 		$41.1M Buy
260,235
+10,768
+4% +$1.87M 0.14% 96
2024
Q1 		$49.4M Sell
249,467
-40,661
-14% -$7.43M 0.18% 80
2023
Q4 		$50.5M Buy
290,128
+45,474
+19% +$7.21M 0.22% 80
2023
Q3 		$38.3M Sell
244,654
-47,185
-16% -$7.81M 0.18% 101
2023
Q2 		$47.9M Buy
291,839
+92,811
+47% +$13.6M 0.22% 78
2023
Q1 		$30.7M Sell
199,028
-114,500
-37% -$18.2M 0.16% 137
2022
Q4 		$41.3M Buy
313,528
+100,526
+47% +$13.7M 0.22% 86
2022
Q3 		$22.8M Buy
213,002
+900
+0.4% +$113K 0.13% 176
2022
Q2 		$22.1M Buy
212,102
+157,439
+288% +$21.3M 0.12% 184
2022
Q1 		$8.13M Buy
54,663
+23,987
+78% +$2.94M 0.04% 290
2021
Q4 		$3.5M Buy
30,676
+109
+0.4% +$11.9K 0.02% 384
2021
Q3 		$3.01M Sell
30,567
-6,200
-17% -$659K 0.01% 409
2021
Q2 		$3.53M Sell
36,767
-3,600
-9% -$337K 0.02% 386
2021
Q1 		$3.24M Buy
40,367
+16,800
+71% +$1.02M 0.02% 398
2020
Q4 		$1.25M Buy
+23,567
New +$1.22M 0.01% 531
2019
Q3 		– Sell
-64,400
Closed -$3.55M – 770
2019
Q2 		$3.55M Buy
64,400
+300
+0.5% +$16.5K 0.03% 352
2019
Q1 		$3.74M Sell
64,100
-12,300
-16% -$721K 0.03% 316
2018
Q4 		$3.96M Buy
+76,400
New +$4.52M 0.03% 212
2017
Q3 		– Sell
-68,900
Closed -$3.99M – 609
2017
Q2 		$3.99M Buy
68,900
+32,500
+89% +$1.91M 0.02% 262
2017
Q1 		$2.17M Buy
+36,400
New +$2.22M 0.01% 315

Other funds holding NUE

State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NUE Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Nucor (NUE) stake by 21% in Q2 2026, selling an estimated $12.4M and leaving 203,235 shares worth $45.3M. The position accounts for 0.1% of the portfolio, ranked #80.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NUE in Q1 2017 and has held it in 28 quarters since. The position peaked at $50.5M in Q4 2023. 1,541 funds tracked by Wall St. Rank hold NUE as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 203,235 shares of Nucor worth $45.3M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 54,752 Nucor shares in Q2 2026, an estimated $12.4M.
  • Nucor made up 0.1% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #80 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Nucor in Q1 2017 and has held it in 28 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Nucor position peaked at $50.5M in Q4 2023.
  • 1,541 funds tracked by Wall St. Rank held Nucor as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.